A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2–specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis

This publication has 22 references indexed in Scilit:

• Localization of cyclooxygenase-2 and regulation of its expression in gastric ulcers in rats
  Gastroenterology, 1998
• Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis
  BMJ, 1996
• A randomized, double-blind comparison of placebo, etodolac, and naproxen on gastrointestinal injury and prostaglandin production
  Gastrointestinal Endoscopy, 1995
• Misoprostol coadministered with diclofenac for prevention of gastroduodenal ulcers
  Digestive Diseases and Sciences, 1995
• A Controlled Study of Ranitidine for the Prevention of Recurrent Hemorrhage from Duodenal Ulcer
  New England Journal of Medicine, 1994
• A controlled study comparing the effects of nabumetone, ibuprofen, and ibuprofen plus misoprostol on the upper gastrointestinal tract mucosa
  Archives of internal medicine (1960), 1993
• A double‐blind gastroscopic evaluation of the effects of etodolac and naproxen on the gastrointestinal mucosa of rheumatic patients
  Journal of Internal Medicine, 1991
• Endoscopic evaluation of etodolac and naproxen, and their relative effects on gastric and duodenal prostaglandins
  Rheumatology International, 1990
• A Randomized Study of Maintenance Therapy with Ranitidine to Prevent the Recurrence of Duodenal Ulcer
  New England Journal of Medicine, 1989
• FDA arthritis advisory committee meeting: Postmarketing surveillance of nonsteroidal antiinflammatory drugs
  Arthritis & Rheumatism, 1985